Search by Drug Name or NDC
NDC 60505-6246-04 Cefepime 2 g/1 Details
Cefepime 2 g/1
Cefepime is a INTRAVENOUS INJECTION, POWDER, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Apotex Corp.. The primary component is CEFEPIME HYDROCHLORIDE.
MedlinePlus Drug Summary
Cefepime injection is used to treat certain infections caused by bacteria including pneumonia, and skin, urinary tract, and kidney infections. Cefepime injection is used in combination with metronidazole (Flagyl) to treat abdominal (stomach area) infections. Cefepime injection is also used to treat patients who have fever and are at high risk for infection because they have a low number of white blood cells. Cefepime injection is in a class of medications called cephalosporin antibiotics. It works by killing bacteria. Antibiotics such as cefepime injection will not work for colds, flu, or other viral infections. Using antibiotics when they are not needed increases your risk of getting an infection later that resists antibiotic treatment.
Related Packages: 60505-6246-04Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Cefepime Injection
Product Information
| NDC | 60505-6246 |
|---|---|
| Product ID | 60505-6246_dcfcbe55-750e-4f29-9ebe-fbf25d4083cd |
| Associated GPIs | |
| GCN Sequence Number | 024095 |
| GCN Sequence Number Description | cefepime HCl VIAL 2 G INJECTION |
| HIC3 | W1Z |
| HIC3 Description | CEPHALOSPORIN ANTIBIOTICS - 4TH GENERATION |
| GCN | 49123 |
| HICL Sequence Number | 010132 |
| HICL Sequence Number Description | CEFEPIME HCL |
| Brand/Generic | Generic |
| Proprietary Name | Cefepime |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Cefepime |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, POWDER, FOR SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 2 |
| Active Ingredient Units | g/1 |
| Substance Name | CEFEPIME HYDROCHLORIDE |
| Labeler Name | Apotex Corp. |
| Pharmaceutical Class | Cephalosporin Antibacterial [EPC], Cephalosporins [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA203704 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 60505-6246-04 (60505624604)
| NDC Package Code | 60505-6246-4 |
|---|---|
| Billing NDC | 60505624604 |
| Package | 10 VIAL, SINGLE-DOSE in 1 CARTON (60505-6246-4) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
| Marketing Start Date | 2022-09-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |